This study was to evaluate the immunophenotype of the CD34+ cell population in PB in patients with newly diagnosed sarcoidosis with reference to the control group and exact characteristics low-differentiated CD34+ cells including DLCO values in sarcoidosis. The gene discussed is CD34; the disease is sarcoidosis.